SST;somatostatin;SMST
EGF;epidermal growth factor;epidermal growth factor (beta-urogastrone)
EGFR;epidermal growth factor receptor;ERBB;epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog);ERBB1
GRB2;growth factor receptor bound protein 2;growth factor receptor-bound protein 2;NCKAP2
SOS
SOS1;SOS Ras/Rac guanine nucleotide exchange factor 1;GINGF;gingival fibromatosis, hereditary, 1;son of sevenless homolog 1 (Drosophila);HGF;GF1
SOS2;SOS Ras/Rho guanine nucleotide exchange factor 2;son of sevenless (Drosophilia) homolog 2;son of sevenless homolog 2 (Drosophila)
Ras
RRAS;related RAS viral (r-ras) oncogene homolog
RRAS2;related RAS viral (r-ras) oncogene homolog 2;TC21
Raf
ARAF;A-Raf proto-oncogene, serine/threonine kinase;ARAF1;v-raf murine sarcoma 3611 viral oncogene homolog 1
BRAF;B-Raf proto-oncogene, serine/threonine kinase;v-raf murine sarcoma viral oncogene homolog B;BRAF1
RAF1;Raf-1 proto-oncogene, serine/threonine kinase;v-raf-1 murine leukemia viral oncogene homolog 1;Raf-1;c-Raf;CRAF
MEK
LAMTOR3;late endosomal/lysosomal adaptor, MAPK and MTOR activator 3;MAP2K1IP1;MAPKSP1;mitogen-activated protein kinase kinase 1 interacting protein 1;MAPK scaffold protein 1;MP1;MAPBP;Ragulator3
MAPK
LAMTOR1;late endosomal/lysosomal adaptor, MAPK and MTOR activator 1;C11orf59;chromosome 11 open reading frame 59;FLJ20625;p18;p27RF-Rho;Pdro;Ragulator1
LAMTOR2;late endosomal/lysosomal adaptor, MAPK and MTOR activator 2;ROBLD3;roadblock domain containing 3;MAPBPIP;MAPKSP1AP;p14;ENDAP;Ragulator2
LAMTOR3P1;late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 pseudogene 1
LAMTOR3P2;late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 pseudogene 2
LAMTOR4;late endosomal/lysosomal adaptor, MAPK and MTOR activator 4;C7orf59;chromosome 7 open reading frame 59
LAMTOR5;late endosomal/lysosomal adaptor, MAPK and MTOR activator 5;HBXIP;hepatitis B virus x interacting protein;XIP;MGC71071
LAMTOR5P1;late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 pseudogene 1;HBXIPP1;hepatitis B virus x interacting protein pseudogene 1;HBXIPL
MCRIP1;MAPK regulated corepressor interacting protein 1;FAM195B;family with sequence similarity 195, member B;family with sequence similarity 195 member B;GRAN2;MCRIP
MCRIP2;MAPK regulated corepressor interacting protein 2;C16orf14;FAM195A;chromosome 16 open reading frame 14;family with sequence similarity 195, member A;family with sequence similarity 195 member A;MGC15416
MCRIP2P1;MAPK regulated corepressor interacting protein 2 pseudogene 1;FAM195CP;family with sequence similarity 195, member C, pseudogene
MCRIP2P2;MAPK regulated corepressor interacting protein 2 pseudogene 2;FAM195DP;MCRIP2P1;family with sequence similarity 195, member D, pseudogene;MAPK regulated co-repressor interacting protein 2 pseudogene 2
MNK
ATP7A;ATPase copper transporting alpha;MNK;Menkes syndrome;ATPase, Cu++ transporting, alpha polypeptide
CDPCR3HD
SRY;sex determining region Y;TDF
LYF1
LEF1;lymphoid enhancer binding factor 1;lymphoid enhancer-binding factor 1;TCF1ALPHA;TCF10;TCF7L3
AML1
RUNX1;runt related transcription factor 1;AML1;CBFA2;acute myeloid leukemia 1;runt-related transcription factor 1;PEBP2A2;AMLCR1
CBFB;core-binding factor beta subunit;core-binding factor, beta subunit;PEBP2B
CEBP
CEBPA;CCAAT/enhancer binding protein alpha;CEBP;CCAAT/enhancer binding protein (C/EBP), alpha;C/EBP-alpha
CPEB1;cytoplasmic polyadenylation element binding protein 1;FLJ13203;CPEB
CAP
CLIP1;CAP-Gly domain containing linker protein 1;RSN;restin (Reed-Steinberg cell-expressed intermediate filament-associated protein);CAP-GLY domain containing linker protein 1;CYLN1;CLIP170;CLIP;CLIP-170
CLIP2;CAP-Gly domain containing linker protein 2;WBSCR4;CYLN2;WBSCR3;cytoplasmic linker 2;Williams-Beuren syndrome chromosome region 3;CAP-GLY domain containing linker protein 2;CLIP-115;KIAA0291;WSCR4;CLIP;WSCR3
CLIP3;CAP-Gly domain containing linker protein 3;CAP-GLY domain containing linker protein 3;CLIPR-59;RSNL1
CLIP4;CAP-Gly domain containing linker protein family member 4;RSNL2;restin-like 2;CAP-GLY domain containing linker protein family, member 4;FLJ21069
CMTR1;cap methyltransferase 1;KIAA0082;FTSJD2;FtsJ methyltransferase domain containing 2;MTr1;ISG95
CMTR2;cap methyltransferase 2;FTSJD1;FtsJ methyltransferase domain containing 1;FLJ11171;AFT;MTr2
CTIF;cap binding complex dependent translation initiation factor;KIAA0427;CBP80/20-dependent translation initiation factor
NCBP1;nuclear cap binding protein subunit 1;NCBP;nuclear cap binding protein subunit 1, 80kD;nuclear cap binding protein subunit 1, 80kDa;CBP80;Sto1
NCBP2;nuclear cap binding protein subunit 2;nuclear cap binding protein subunit 2, 20kD;nuclear cap binding protein subunit 2, 20kDa;NIP1;CBP20;Cbc2
NCBP2L;nuclear cap binding protein subunit 2 like
NCBP3;nuclear cap binding subunit 3;C17orf85;chromosome 17 open reading frame 85;HSA277841;ELG
TCAP;titin-cap;LGMD2G;limb girdle muscular dystrophy 2G (autosomal recessive);titin-cap (telethonin);T-cap;TELE;telethonin;CMD1N
GATA3;GATA binding protein 3;GATA-binding protein 3;HDR
ZN;ZINC ION
MYOD
MDFI;MyoD family inhibitor;I-mfa
MDFIC;MyoD family inhibitor domain containing;HIC;MDFIC1
MDFIC2;MyoD family inhibitor domain containing 2
CDXA
GATA1;GATA binding protein 1;GF1;GATA-binding protein 1 (globin transcription factor 1);globin transcription factor 1;ERYF1;NFE1;GATA-1;NF-E1
ACT;ACETATE ION
GATA2;GATA binding protein 2;GATA-binding protein 2;NFE1B
AP4
REPIN1;replication initiator 1;ZNF464;zinc finger protein 464 (RIP60);RIP60;AP4;H_DJ0584D14.12;Zfp464
USF
USF1;upstream transcription factor 1;UEF;MLTFI;bHLHb11
ATF
BATF;basic leucine zipper ATF-like transcription factor;basic leucine zipper transcription factor, ATF-like;B-ATF;SFA-2;BATF1
BATF2;basic leucine zipper ATF-like transcription factor 2;basic leucine zipper transcription factor, ATF-like 2;MGC20410
BATF3;basic leucine zipper ATF-like transcription factor 3;basic leucine zipper transcription factor, ATF-like 3;JUNDM1;SNFT;JDP1
CREBZF;CREB/ATF bZIP transcription factor;ZF
ATF2;activating transcription factor 2;CREB2;cAMP responsive element binding protein 2;TREB7;CRE-BP1;HB16
CREB
CREBBP;CREB binding protein;RSTS;Rubinstein-Taybi syndrome;RTS;CBP;KAT3A
CRTC1;CREB regulated transcription coactivator 1;MECT1;mucoepidermoid carcinoma translocated 1;KIAA0616;FLJ14027;TORC1
CRTC2;CREB regulated transcription coactivator 2;TORC2
CRTC3;CREB regulated transcription coactivator 3;FLJ21868
53W;5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[2-(4-methoxyphenyl)ethyl]-1-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole
CREBP1CJUN
